JFGIW
OGEN icon

Johnson Financial Group Inc (Wisconsin)’s Oragenics OGEN Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 890

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s OGEN Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in Oragenics (OGEN) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #890 among its holdings.

19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of Oragenics worth $1 as of Q1 2026.
  • Oragenics was a new Johnson Financial Group Inc (Wisconsin) position in Q1 2026.
  • Oragenics made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #890 holding.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.